Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/302% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria Oral Tobacco Products by Year
Oral Tobacco Products — Reported Operating Companies Income (Reported OCI, $M) ($M)
Altria Oral Tobacco Products: $1,828M in FY2025, up 26.2% from a year earlier. That is the highest of the 12 years on record here.
Latest, FY2025
1,828
Period ended Dec 31, 2025
Change on a year earlier
+26.2%
1,449 in FY2024
History
12 years
Since FY2014
Sources
10
Documents cited below
Where the FY2025 figure comes from
“|| Reported OCI | $ | 438 | $ | 453 | (3.3) | % | $ | 1,828 | $ | 1,449 | 26.2 | %”
Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria Oral Tobacco Products ($M), annual FY2014–FY2025 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/oral-rep-oci
See every metric in the Altria KPI table. Data updated Nov 2, 2026.